Toronto Dominion Bank
PBMWW

Toronto Dominion Bank’s Psyence Biomedical Warrant PBMWW Stock Holding History

Toronto Dominion Bank’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Sell
503,012
-300
-0.1% -$9 ﹤0.01% 2079
2026
Q1 		$9.06K Hold
503,312
– – ﹤0.01% 1937
2025
Q4 		$9.56K Hold
503,312
– – ﹤0.01% 1826
2025
Q3 		$12.6K Buy
503,312
+100
+0% +$3 ﹤0.01% 1739
2025
Q2 		$10.2K Buy
+503,212
New +$8.05K ﹤0.01% 1630

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Toronto Dominion Bank's PBMWW Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Psyence Biomedical Warrant (PBMWW) stake by 0.06% in Q2 2026, selling an estimated $9 and leaving 503,012 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Toronto Dominion Bank first reported a position in PBMWW in Q2 2025 and has held it in 5 quarters since. The position peaked at $12.6K in Q3 2025. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

  • Toronto Dominion Bank held 503,012 shares of Psyence Biomedical Warrant worth $12.1K as of Q2 2026.
  • Toronto Dominion Bank sold 300 Psyence Biomedical Warrant shares in Q2 2026, an estimated $9.
  • Psyence Biomedical Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2079 holding.
  • Toronto Dominion Bank first reported a position in Psyence Biomedical Warrant in Q2 2025 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Psyence Biomedical Warrant position peaked at $12.6K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.